Stockholders’ Equity - Narrative (Details) - $ / shares |
3 Months Ended | |
---|---|---|
Mar. 31, 2023 |
Jun. 03, 2021 |
|
Common Stock Warrants | ||
Subsidiary, Sale of Stock [Line Items] | ||
Outstanding, beginning balance (in shares) | 36,554 | |
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice | $ 16.23 | |
Employee Stock Purchase Plan | ||
Subsidiary, Sale of Stock [Line Items] | ||
Grant (in shares) | 320,521 | 400,000 |
Offering period | 6 months |
X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the other than stock option plan. No definition available.
|
X | ||||||||||
- Definition Share-based Compensation Arrangement by Share-based Payment Award, Offering Period No definition available.
|
X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|